Halis Türker Balaydın

Halis Türker Balaydın

Auto-generated profile, based on publicly available information

Halis Türker Balaydın

Education Faculty Recep Tayyip Erdogan University Rize Türkiye

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2010 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
HBHalis Türker Balaydın
Halis Türker Balaydın
IGİlhami Gülçin
İlhami Gülçin
AMAbdullah Menzek
Abdullah Menzek
SGSüleyman Göksu
Süleyman Göksu
EŞErtan Şahin
Ertan Şahin
Bromination of bis(3,4-dimethoxyphenyl)methanone (5) gave four products (6–9) with mono, di, tri, and tetra Br under different conditions. Reduction and demethylation reactions of product 9 with tetra Br were performed, consecutively and a natural product, 5,5′-methylene bis(3,4-dibrombenzene-1,2-diol) (1), was obtained with a 53% yield. Five derivatives, (13–17) (bromophenols), of 1 were also synthesised. The antioxidant and radical scavenging activities of bromophenols 1 and 13–17 were determined by employing various in vitro assays such as 1,1-diphenyl-2-picryl-hydrazyl free radical (DPPH•), 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS•+), N,N-dimethyl-p-phenylenediamine dihydrochloride radical cation (DMPD•+), and superoxide anion radical (O2•-) scavenging, reducing ability determination by the Fe3+-Fe2+ and Cu2+-Cu+ cupric reducing antioxidant capacity (CUPRAC) transformation methods, hydrogen peroxide scavenging, and ferrous ion (Fe2+) chelating activities. Moreover, these activities were compared to those of synthetic standard antioxidant compounds such as butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), α-tocopherol, and trolox. The results showed that the synthesised bromophenols had effective antioxidant power.

1 February 2011 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
SDSerdar Durdagi
Serdar Durdagi
MSMurat Senturk
Murat Senturk
DEDeniz Ekinci
Deniz Ekinci
HBHalis Türker Balaydın
Halis Türker Balaydın
SGSüleyman Göksu
Süleyman Göksu
CSClaudiu T. Supuran
Claudiu T. Supuran

1 August 2012 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HBHalis T. Balaydın
Halis T. Balaydın
MSMurat Senturk
Murat Senturk
SGSüleyman Göksu
Süleyman Göksu
AMAbdullah Menzek
Abdullah Menzek

1 February 2012 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
HBHalis T. Balaydın
Halis T. Balaydın
MSMurat Senturk
Murat Senturk
AMAbdullah Menzek
Abdullah Menzek

7 May 2013 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
YAYusuf Akbaba
Yusuf Akbaba
HBHalis Türker Balaydın
Halis Türker Balaydın
AMAbdullah Menzek
Abdullah Menzek
SGSüleyman Göksu
Süleyman Göksu
EŞErtan Şahin
Ertan Şahin
ESErcan Soydan
Ercan Soydan

1 August 2011 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
HBHalis Türker Balaydin
Halis Türker Balaydin
SDSerdar Durdagi
Serdar Durdagi
DEDeniz Ekinci
Deniz Ekinci
MSMurat Senturk
Murat Senturk
SGSüleyman Göksu
Süleyman Göksu
AMAbdullah Menzek
Abdullah Menzek
Carbonic anhydrase inhibitors (CAI) are valuable molecules as they have several therapeutic applications, including anti-glaucoma activity. In this study, inhibition of three human carbonic anhydrase (hCA, EC 4.2.1.1) isozymes I, II and VI with a series of bisphenol and bromophenol derivatives was investigated. Molecular docking studies of a set of such inhibitors within CA I and II were also performed. K(I) values of the molecules 2-9 were in the range of 10.025-892.109 μM for hCA I, 1.437-59.107 μM for hCA II and 11.143-919.182 μM for hCA VI, respectively. Reported inhibitory activities of molecules 2-9 will assist in better understanding of structure-activity relationship studies of CAI.